148 related articles for article (PubMed ID: 32592558)
1. Vaccination rates for Syrian population under temporary protection in Turkey.
Öztaş D; Kurt B; Akbaba M; Akyol M; Mollahaliloğlu S; Topaç O
Cent Eur J Public Health; 2020 Jun; 28(2):130-134. PubMed ID: 32592558
[TBL] [Abstract][Full Text] [Related]
2. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
Sanftenberg L; Schrörs HJ; Schelling J
Vaccine; 2016 Jul; 34(34):3938-41. PubMed ID: 27318420
[TBL] [Abstract][Full Text] [Related]
3. Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018.
Mellou K; Silvestros C; Saranti-Papasaranti E; Koustenis A; Pavlopoulou ID; Georgakopoulou T; Botsi C; Terzidis A
Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290391
[TBL] [Abstract][Full Text] [Related]
4. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
5. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
[TBL] [Abstract][Full Text] [Related]
6. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
Alfredsson R; Svensson E; Trollfors B; Borres MP
Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
[TBL] [Abstract][Full Text] [Related]
7. Successes and challenges for preventing measles, mumps and rubella by vaccination.
Bankamp B; Hickman C; Icenogle JP; Rota PA
Curr Opin Virol; 2019 Feb; 34():110-116. PubMed ID: 30852425
[TBL] [Abstract][Full Text] [Related]
8. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
9. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
[TBL] [Abstract][Full Text] [Related]
10. Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.
Beleni AI; Borgmann S
Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30065192
[TBL] [Abstract][Full Text] [Related]
11. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
[TBL] [Abstract][Full Text] [Related]
12. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
13. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
14. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies.
Edmunds WJ; Gay NJ; Kretzschmar M; Pebody RG; Wachmann H;
Epidemiol Infect; 2000 Dec; 125(3):635-50. PubMed ID: 11218214
[TBL] [Abstract][Full Text] [Related]
15. Measles, mumps, and rubella vaccination coverage: an ecological study of primary health care and socio-economic factors in Catalonia, Spain.
Martínez-Marcos M; Reñé-Reñé A; Zabaleta-Del-Olmo E; Guiriguet C; Gómez-Durán EL; Cabezas-Peña C
J Public Health Policy; 2024 Jun; 45(2):299-318. PubMed ID: 38664542
[TBL] [Abstract][Full Text] [Related]
16. A new combination vaccine for measles, mumps, rubella and varicella.
Zareba G
Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
[TBL] [Abstract][Full Text] [Related]
17. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
Vyse AJ; Gay NJ; White JM; Ramsay ME; Brown DW; Cohen BJ; Hesketh LM; Morgan-Capner P; Miller E
Epidemiol Rev; 2002; 24(2):125-36. PubMed ID: 12762088
[No Abstract] [Full Text] [Related]
18. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
Böttiger M; Christenson B; Strandell A; Romanus V
Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
Amela C; Pachón I; de Ory F
Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
